These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 4511385
1. [L-dopa treatment of parkinsonism]. Szulc-Kuberska J, Niewodniczy A, Poźniak-Patewicz E, Wolczyk-Orzechowska M. Neurol Neurochir Pol; 1973; 7(1):63-8. PubMed ID: 4511385 [No Abstract] [Full Text] [Related]
2. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report. Wycis HT. Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056 [No Abstract] [Full Text] [Related]
3. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor]. Agnoli A, Casacchia M, Reitano M, Ruggieri S, Barba C, Zamponi A. Minerva Med; 1972 Dec 12; 63(89):4853-61. PubMed ID: 4566743 [No Abstract] [Full Text] [Related]
4. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports]. Rosati G, Agnetti V, Mura F, Granieri E. Minerva Med; 1974 May 02; 65(33):1811-23. PubMed ID: 4602058 [No Abstract] [Full Text] [Related]
8. [Treatment of Parkinson's disease with L-dopa]. Guglielmi L, Vecchi L. Clin Ter; 1970 May 15; 53(3):259-69. PubMed ID: 4917328 [No Abstract] [Full Text] [Related]
9. [Side effects occurring in the course of treatment of parkinsonism with L-dopa]. Kuran W. Neurol Neurochir Pol; 1973 May 15; 7(4):587-94. PubMed ID: 4583001 [No Abstract] [Full Text] [Related]
10. Amantadine hydrochloride in treatment of Parkinsonism. Nagaswami S, Nagaswami R. Dis Nerv Syst; 1973 May 15; 34(5):253-8. PubMed ID: 4782280 [No Abstract] [Full Text] [Related]
11. L-dopa for parkinsonism. Reveno WS, Bauer RB, Rosenbaum H. Geriatrics; 1973 Jan 15; 28(1):86-8. PubMed ID: 4683093 [No Abstract] [Full Text] [Related]
12. [Long term treatment of a parkinsonism with l-dopa]. Presthus J. Tidsskr Nor Laegeforen; 1973 Oct 10; 93(28):2111-3. PubMed ID: 4590069 [No Abstract] [Full Text] [Related]
13. [Current treatment of Parkinson syndrome with L-dopa]. Gerstendbrand F, Gründig E, Musiol A. Pol Tyg Lek; 1972 May 22; 27(21):798-800. PubMed ID: 4555002 [No Abstract] [Full Text] [Related]
14. L-dopa therapy in Parkinson's disease. Lipman IJ. Va Med Mon (1918); 1971 May 22; 98(5):242-8. PubMed ID: 4931138 [No Abstract] [Full Text] [Related]
15. [Long-term treatment of Parkinsonism with L-dopa]. Presthus J, Holmsen R. Tidsskr Nor Laegeforen; 1972 Nov 30; 92(33):2262-6. PubMed ID: 4630916 [No Abstract] [Full Text] [Related]
16. Modification of Parkinsonism--chronic treatment with L-dopa. Cotzias GC, Papavasiliou PS, Gellene R. N Engl J Med; 1969 Feb 13; 280(7):337-45. PubMed ID: 4178641 [No Abstract] [Full Text] [Related]
17. [Management of Parkinson's syndrome using levadopa. Results of a long-term study]. Wälzholz U. Dtsch Med Wochenschr; 1972 Apr 28; 97(17):686 passim. PubMed ID: 4554502 [No Abstract] [Full Text] [Related]
18. L-dopa in the treatment of Parkinsonism; a preliminary appraisal. Stellar S, Mandell S, Waltz JM, Cooper IS. J Neurosurg; 1970 Mar 28; 32(3):275-80. PubMed ID: 5416909 [No Abstract] [Full Text] [Related]
19. [L-tryptophan therapy of DOPA psychoses]. Birkmayer W, Neumayer E. Nervenarzt; 1972 Feb 28; 43(2):76-8. PubMed ID: 4501978 [No Abstract] [Full Text] [Related]
20. Interactions of L-dopa and amantadine in patients with Parkinsonism. Cox B, Danta G, Schnieden H, Yuill GM. J Neurol Neurosurg Psychiatry; 1973 Jun 28; 36(3):354-61. PubMed ID: 4714097 [Abstract] [Full Text] [Related] Page: [Next] [New Search]